| Literature DB >> 32878615 |
Kazuya Shinmura1, Satoshi Kato1, Satoru Demura2, Noriaki Yokogawa1, Noritaka Yonezawa1, Takaki Shimizu1, Norihiro Oku1, Ryo Kitagawa1, Makoto Handa1, Ryohei Annen1, Hideki Murakami3, Hiroyuki Tsuchiya1.
Abstract
BACKGROUND: There have been several reports of instrumentation failure after three-column resections such as total en bloc spondylectomy (TES) for spinal tumors; however, clinical outcomes of revision surgery for instrumentation failure after TES are seldom reported. Therefore, this study assessed the clinical outcomes of revision surgery for instrumentation failure after TES.Entities:
Keywords: Bone fusion; Cobalt chromium; Instrumentation failure; Liquid nitrogen; Revision surgery; Total en bloc spondylectomy
Mesh:
Year: 2020 PMID: 32878615 PMCID: PMC7469324 DOI: 10.1186/s12891-020-03622-6
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1Schema of revision surgery after instrumentation failure. a The scar tissue of the resected vertebral area and the adjacent laminae are exposed. b Fresh autologous bone strut graft harvested from the iliac crest is placed on the scar tissue of the resected vertebral area to form a bridge between the adjacent laminae. c To increase stability, additional rods are applied
Details of patients who experienced instrumentation failure
| No. | Age | Sex | BMI | Type of tumor | RT | Resection level | Broken parts in instrumentation failure | Duration after TES (mo) | Back pain | Neurological deterioration | Ambulatory | Revision surgery |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 39 | M | 24.0 | thyroid cancer | no | T4 | 2 rods | 42 | + | – | yes | yes |
| 2 | 63 | F | 21.0 | thyroid cancer | no | T4, 5, 6 | 1 rod | 74 | + | – | yes | yes |
| 3 | 57 | F | 22.3 | parotid cancer | no | T5, 6 | 2 rods | 92 | + | – | yes | yes |
| 4 | 59 | F | 22.6 | breast cancer | yes | T6, 7 | 2 rods | 24 | – | bilateral leg weakness | no | yes |
| 5 | 68 | M | 22.4 | hepatocellular carcinoma | yes | T7 | 2 rods | 51 | – | bilateral leg weakness | yes | yes |
| 6 | 24 | M | 22.0 | leiomyosarcoma | no | T7,8 | 1 rod | 29 | + | – | yes | yes |
| 7 | 41 | F | 16.4 | synovial sarcoma | yes | T8, 9 | 2 rods | 37 | + | – | yes | yes |
| 8 | 68 | M | 23.2 | renal cell carcinoma | no | T8, 9 | 2 rods | 18 | + | – | yes | yes |
| 9 | 59 | M | 24.2 | renal cell carcinoma | no | T8, 9, 10 | 2 rods | 11 | + | – | no | yes |
| 10 | 59 | M | 24.3 | lung cancer | no | T8,9, 10 | 2 rods and cage | 25 | + | bilateral leg weakness | no | yes |
| 11 | 66 | F | 18.4 | esophageal cancer | no | T9 | 1 rod | 17 | + | – | yes | yes |
| 12 | 26 | M | 27.0 | epithelioid sarcoma | no | T10 | 2 rods | 34 | + | bilateral leg paresthesia | yes | yes |
| 13 | 40 | M | 26.3 | liposarcoma | no | T10 | 1 rod | 38 | – | – | yes | yes |
| 14 | 45 | M | 23.6 | chondrosarcoma | no | T10 | 1 rod | 32 | + | – | yes | yes |
| 15 | 70 | M | 25.2 | unknown | no | T10, 11 | 2 rods | 11 | + | – | no | yes |
| 16 | 14 | M | 24.3 | Ewing’s sarcoma | no | T12 | 2 screws | 22 | – | – | yes | yes |
| 17 | 48 | M | 28.4 | renal cell carcinoma | no | T12, L1 | 2 rods | 19 | + | bilateral leg paresthesia | yes | yes |
| 18 | 66 | F | 22.4 | breast cancer | no | L1 | 1 rod | 18 | + | – | yes | yes |
| 19 | 16 | M | 22.8 | chordoma | no | L1, 2 | 2 rods and cage | 21 | + | – | yes | yes |
| 20 | 64 | M | 19.9 | aggressive hemangioma | no | L2 | 1 rod | 23 | + | – | yes | yes |
| 21 | 49 | F | 30.9 | giant cell tumor | no | L4,5 | 2 rods | 39 | + | bilateral leg paresthesia | no | yes |
| 22 | 25 | F | 17.2 | giant cell tumor | no | L4 | cage and 1 screw | 31 | + | bilateral leg paresthesia | yes | yes |
| 23 | 50 | M | 32.3 | lung cancer | no | L5 | 2 rods | 24 | + | bilateral leg pain | no | yes |
| 24 | 21 | F | 24.3 | giant cell tumor | no | T11 | cage | 24 | – | – | yes | no |
| 25 | 41 | F | 22.2 | breast cancer | no | L3 | 2 screws | 35 | – | – | yes | no |
| 26 | 70 | M | 20.8 | renal cell carcinoma | yes | L3 | 1 rod | 30 | – | – | yes | no |
BMI body mass index, RT radiation therapy
Details of patients who underwent revision surgery
| No. | Resection level | Operation time (min) | bleeding (ml) | The number of rod | Composition of rod | Extended segmental fixation | Bone graft | Complications | Duration after revision surgery (mo) | Bone fusion | Re-instrumentation failure |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | T4 | 240 | 50 | 2 | Ti | – | posterior | – | 58 | anterior and posterior | no |
| 2 | T4, 5, 6 | 214 | 40 | 4 | Cocr | – | posterior | – | 22 | anterior and posteriora | no |
| 3 | T5, 6 | 173 | 120 | 4 | Cocr | – | posterior | – | 9 | unachieveda | no |
| 4 | T6, 7 | 248 | 20 | 4 | Cocr | 3-above 3-below | – | – | 28 | anterior | no |
| 5 | T7 | 222 | 50 | 3 | Cocr | 2-above 4-below | posterior | delayed wound healing | 17 | posteriora | no |
| 6 | T7,8 | 213 | 110 | 2 | Cocr | – | – | – | 31 | anterior | no |
| 7 | T8, 9 | 208 | 250 | 4 | Ti | – | posterior | – | 32 | anterior and posterior | no |
| 8 | T8, 9 | 132 | 20 | 4 | Cocr | 3-above 3-below | posterior | – | 13 | unachieveda | no |
| 9 | T8, 9, 10 | 121 | 120 | 4 | Cocr | – | posterior | – | 44 | anterior and posterior | no |
| 10 | T8,9, 10 | 239 | 130 | 4 | Cocr | 3-above 3-below | posterior and anterior | – | 38 | anterior and posterior | no |
| 11 | T9 | 164 | 50 | 4 | Cocr | – | posterior | SSI | 35 | anterior and posterior | no |
| 12 | T10 | 168 | 130 | 4 | Cocr | – | posterior | – | 32 | posterior | no |
| 13 | T10 | 150 | 20 | 4 | Cocr | – | posterior | – | 37 | anterior and posterior | no |
| 14 | T10 | 156 | 30 | 4 | Cocr | – | posterior | – | 40 | posterior | no |
| 15 | T10, 11 | 235 | 270 | 2 | Ti | 2-above 4-below | posterior and anterior | – | 5 | unachieveda | no |
| 16 | T12 | 224 | 30 | 4 | Cocr | 2-above 3-below | posterior | – | 28 | anterior and posterior | no |
| 17 | T12, L1 | 203 | 20 | 4 | Cocr | – | posterior | – | 36 | anterior and posterior | no |
| 18 | L1 | 143 | 50 | 4 | Cocr | – | posterior | – | 42 | anterior and posterior | no |
| 19 | L1, 2 | 287 | 80 | 4 | Cocr | – | posterior and anterior | – | 52 | anterior and posterior | no |
| 20 | L2 | 216 | 50 | 4 | Cocr | – | posterior | – | 46 | anterior and posterior | no |
| 21 | L4,5 | 262 | 115 | 4 | Cocr | – | posterior | SSI | 49 | posterior | no |
| 22 | L4 | 241 | 220 | 2 | Ti | – | posterior | – | 60 | posterior | no |
| 23 | L5 | 239 | 250 | 4 | Cocr | – | posterior | – | 56 | posterior | no |
Cocr cobalt chromium, Ti titanium alloy, SSI surgical site infection
afollow up period after revision surgery was 2 years or less
Fig. 2Case 18. A 66-year-old woman with breast cancer metastasis at L1. a Preoperative sagittal T2 magnetic resonance image revealing tumor involvement at L1. b Lateral radiograph revealing pathological fracture at L1. c Lateral radiograph after total en bloc spondylectomy. d Radiographs at 18 months after surgery revealing increased local kyphosis angle between T12 and L2. e Coronal computed tomography (CT) scan revealing breakage of the left rod. f Posterior instrumentation is exposed using the previous midline incision. g The left rod is broken at the area proximal to the L2 pedicle screw. h Loosening pedicle screw at the left T11 level is replaced, and four cobalt chromium rods are inserted. i Autologous bone graft is placed on adjacent T12 and L2 lamina and scar tissue of the resected L1 lamina area. j, k Radiograph after revision surgery. l Sagittal CT scan at 42 months after revision surgery revealing bone fusion within the cage and at the posterior bone graft